Specific renal delivery of sugar-modified low-molecular-weight peptides

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 888-897

  Suzuki, Kokichi ^a,c   Susaki, Hiroshi ^a,d   Okuno, Satoshi ^a,e   Yamada, Harutami ^a,e   Watanabe, Hiroshi K ^a,c   Sugiyama, Yuichi ^b  

^a Drug Delivery System Institute Ltd   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c MEIJI SEIKA KAISHA LTD   (Japan)

^d DAIICHI SANKYO CO   (Japan)

^e MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN DERIVATIVE; INULIN; OXYTOCIN; PEPTIDE; SUGAR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG TRANSPORT; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY MICROSOME; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT;

EID: 0032986736     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bourne Y, Tilbeurgh H and Cambillau C (1993) Protein-carbohydrate interactions. Curr Opin Struct Biol 3:681-686.
2. Chaudhuri G, Verbeugen C, Pardridge WM and Judd HL (1987) Selective availability of protein bound estrogen and estrogen conjugates to the rat kidney. J Endocrinol Invest 10:283-290.
3. Chiu MH, Tamura T, Wadhwa MS and Rice KG (1994) In vivo targeting function of N-linked oligosaccharides with terminating galactose and N-acetylgalactosamine residues. J Biol Chem 269:16195-16202.
4. Elfarra AA, Duescher RJ, Hwang IY, Sicuri AR and Nelson JA (1995) Targeting 6-thioguanine to the kidney with S-(guanin-6-yl)-L-cysteine. J Pharmacol Exp Ther 274:1298-1304.
5. Elgavish S and Shaanan B (1997) Lectin-carbohydrate interaction: Different folds, common recognition principles. Trends Biochem Sci 22:462-467.
6. Franssen EJF, Koiter J, Kuipers CAM, Bruins AP, Moolenaar F, de Zeeuw D, Kruizinga WH, Kollogg RM and Meijer DKF (1992) Low-molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. J Med Chem 35:1246-1259.
7. Hediger MA and Rhoads DB (1994) Molecular physiology of sodium-glucose cotransporters. Physiol Rev 74:993-1026.
8. Hori R, He YL, Saito Y, Kamiya A and Tanigawara Y (1991) Moment analysis of drug disposition in kidney. V: In vivo transepithelial transport of p-aminohippurate in rat kidney. J Pharmacokinet Biopharm 19:51-70.
9. Horton D, Priebe W and Sznaidman M (1990) Iodoalkoxylation of 1,5-anhydro-2-deoxy-hex-1-enitols (glycals). Carbohydr Res 205:71-86.
10. Kann N, Rein T, Akermark B and Helquist P (1990) New functionalized Horner-Wadsworth-Emmons reagents: Useful building blocks in the synthesis of polysaturated aldehydes. A short synthesis of (±)-(E, E,)-coriolic acid. J Org Chem 55: 5312-5323.
11. Karlsson KA (1991) Glycobiology: A growing field for drug design. Trends Pharmacol Sci 12:265-272.
12. Kim DC, Hanano M, Sawada Y, Iga T and Sugiyama Y (1991) Kinetic analysis of clearance of epidermal growth factor in isolated perfused rat kidney. Am J Physiol 261:F988-F997.
13. Kim DC, Sugiyama Y, Satoh H, Fuwa T, Iga T and Hanano M (1988) Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J Pharm Sci 77:200-207.
14. Kojima K, Ogawa HK, Seno N, Yamamoto K, Irimura T, Osawa T and Matsumoto I (1992) Carbohydrate-binding proteins in bovine kidney have consensus amino acid sequences of annexin family proteins. J Biol Chem 267:20536-20539.
15. Kojima K, Yamamoto K, Irimura T, Osawa T, Ogawa H and Matsumoto I (1996) Characterization of carbohydrate-binding protein p33/41. J Biol Chem 271:7679-7685.
16. Kuwabara T, Kato Y, Kobayashi S, Suzuki H and Sugiyama Y (1994) Nonlinear pharmacokinetics of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim): Species differences among rats, monkeys and humans. J Pharmacol Exp Ther 271:1535-1543.
17. Kuwabara T, Utimura T, Takai K, Kobayashi H, Kobayashi S and Sugiyama Y (1995b) Saturable uptake of a recombinant human granulocyte colony-stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in vivo. J Pharmacol Exp Ther 273:1114-1122.
18. Kuwabara T, Utimura T, Kobayashi H, Kobayashi S and Sugiyama Y (1995a) Receptor-mediated clearance of G-CSF derivative nartograstim in bone marrow of rats. Am J Physiol 269:E1-E9.
19. Liu KX, Kato Y, Narukawa M, Kim DC, Hanano M, Higuchi O, Nakamura T and Sugiyama Y (1992) Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am J Physiol 263:G642-G649.
20. Matsumoto I, Kitagawa H, Iida N, Saito Y and Seno N (1986) Mammalian kidney lectin. Carbohydr Res 161:261-270.
21. Monsigny M, Roche AC, Midoux P and Mayer R (1994) Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Adv Drug Delivery Rev 14:1-24.
22. Palomino E (1994) Carbohydrate handles as natural resources in drug delivery. Adv Drug Delivery Rev 13:311-323.
23. Pager AM (1996) Molecular cloning and functional expression of a sodium-dicarboxylate cotransporter from human kidney. Am J Physiol 270:F642-F648.
24. Pang KS and Rowland M (1977) Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and "parallel-tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 5:625-653.
25. Pricer WE and Ashwell G (1971) The binding of desialylated glycoproteins by plasma membranes of rat liver. J Biol Chem 248:4825-4833.
26. Quiocho FA (1989) Protein-carbohydrate interactions: basic molecular features. Pure Appl Chem 61:1293-1306.
27. Sadee W, Drubbisch V and Amidon GL (1995) Biology of membrane transport proteins. Pharm Res 12:1823-1837.
28. Saito H, Masuda S and Inui K (1996) Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 271:20719-20725.
29. Sasaki A, Murahashi N, Yamada H and Morikawa A (1995) Synthesis of novel galactosyl ligands for liposomes and influence of the space on accumulation in the rat liver. Biol Pharm Bull 18:740-746.
30. Susaki H, Suzuki K, Ikeda M, Yamada H and Watanabe HK (1994) Synthesis of artificial glycoconjugates of arginine-vasopressin and their antidiuretic activities. Chem Pharm. Bull 42:2090-2096.
31. Susaki H, Suzuki K, Ikeda M, Yamada H and Watanabe HK (1998) Synthesis of novel glycoconjugates of arginine-vasopressin and their antidiuretic activities. Chem Pharm Bull 48:1530-1537.
32. Stassen FL, Erickson RW, Huffman WF, Stefankiewics J, Sulat L and Wiebelhaus VD (1982) Molecular mechanisms of novel antidiuretic antagonists: Analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney. J Pharmacol Exp Ther 223:50-54.
33. Thorens B (1996) Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol 270:G541-G553.
34. Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3:97-130.
35. Vyas NK (1991) Atomic features of protein-carbohydrate interactions. Curr Opin Struct Biol 1:732-740.
36. Yanai S, Sugiyama Y, Iga T, Fuwa T and Hanano M (1990) Kinetic analysis of the downregulation of epidermal growth factor receptors in rats in vivo. Am J Physiol 258:C593-C598.